<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2020</study_start_year><condition>Gastric Cancer</condition><condition>Colorectal Cancer</condition><condition>Carcinoma, Hepatocellular</condition><condition>Pancreatic Cancer</condition><condition>Hepatocellular Cancer</condition><condition>Liver Neoplasms</condition><condition>Neoplasms</condition><disease>Gastric Cancer</disease><disease>Colorectal Cancer</disease><disease>Carcinoma, Hepatocellular</disease><disease>Pancreatic Cancer</disease><disease>Hepatocellular Cancer</disease><disease>Liver Neoplasms</disease><disease>Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2311939</full_dataset_link><location>China</location><study_start_month>7</study_start_month><keyword>Ascorbic Acid</keyword><keyword>Metformin</keyword><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors</name><description>This is an open, prospective, single-arm, multi-cohort clinical study to evaluate the efficacy and safety of high-dose vitamin C combined with metformin in the treatment of malignant tumors.</description><dates><creation>2020-07-15</creation></dates><accession>2311939</accession><cross_references><ClinicalTrials___gov>NCT04033107</ClinicalTrials___gov></cross_references></HashMap>